INTERNATIONAL PATENT: BAUSCH HEALTH IRELAND LIMITED FILES APPLICATION FOR "METHODS FOR PREVENTING, TREATING, OR AMELIORATING ULCERATIVE COLITIS IN CERTAIN PATIENT POPULATIONS WITH AMISELIMOD"

GENEVA, July 2 -- BAUSCH HEALTH IRELAND LIMITED (3013 Lake DriveCitywest Business CampusDublin, 24) filed a patent application (PCT/IB2024/063070) for "METHODS FOR PREVENTING, TREATING, OR AMELIORATING ULCERATIVE COLITIS IN CERTAIN PATIENT POPULATIONS WITH AMISELIMOD" on Dec 20, 2024. With publication no. WO/2025/134072, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PILLAI, Radhakrishnan (c/o Bausch Health US, LLC400 Somerset Corporate Blvd.Bridgewater, New Jersey 08807), ISRAEL, Robert J. (c/o Bausch Health US, LLC400 ...